Century Therapeutics, Inc.
USD2.17
-0.19 (-8.05%)
CEO
Brent Pfeiffenberger
IPO Date
2021-06-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.26
Prev. Close
$2.36
Day Low
$2.14
Day High
$2.37
52W Low
$0.43
52W High
$3.04
Market Cap
$0.19B
Volume
1.10M
| 264 |
| $2.34 |
| 10 Apr 2026 | Murphy Martin Patrick | director | A-Award | Acquired | 88,000 | $0.59 |
| 10 Apr 2026 | Murphy Martin Patrick | — | Disposed | 0 | $0.00 |
| 3 Apr 2026 | Cowan Chad | Chief Scientific Officer | F-InKind | Disposed | 1,365 | $2.19 |
| 16 Mar 2026 | Carr Douglas | SVP Finance & Operations | S-Sale | Disposed | 7,043 | $2.55 |
| 16 Mar 2026 | Russotti Gregory | See Remarks | S-Sale | Disposed | 10,076 | $2.55 |
| 13 Mar 2026 | Pfeiffenberger Brent | director, officer: President and CEO | F-InKind | Disposed | 55,397 | $2.73 |
| 13 Mar 2026 | Cowan Chad | Chief Scientific Officer | F-InKind | Disposed | 1,431 | $2.73 |
| 11 Mar 2026 | Russotti Gregory | See Remarks | S-Sale | Disposed | 479 | $2.54 |